|1|Reduction of bladder activity on FDG PET/CT scan in patients with urinary bladder carcinoma. A prospective study with a patient-friendly protocol. (25345433)
Tsai S.C.... Lin W.Y.
|2|BK virus-associated urinary bladder carcinoma in transplant recipients: productive or nonproductive polyomavirus infections in tumor cells? (24262020)
Nickeleit V.... Kenan D.J.
|3|Targeting epidermal growth factor receptor/human epidermal growth factor receptor 2 signalling pathway by a dual receptor tyrosine kinase inhibitor afatinib for radiosensitisation in murine bladder carcinoma. (23153706)
Tsai Y.C.... Cheng J.C.
|4|The diagnostic accuracy of multidetector computed tomography with multiplanar reformatted imaging and virtual cystoscopy in the early detection and evaluation of bladder carcinoma: comparison with conventional cystoscopy. (22623028)
Amin M.F.... Abd El Hamid A.M.
|5|ErbB receptor tyrosine kinase family expression levels in urothelial bladder carcinoma. (23333248)
Gunes S.... Bagci H.
|6|Detection of deleted in malignant brain tumors 1 and runt-related transcription factor 3 gene expressions in bladder carcinoma. (21956756)
Dodurga Y.... GA1ndA1z C.
|7|Characteristics of lymph node metastases defining the outcome after radical cystectomy of urothelial bladder carcinoma. (22914320)
Nakagawa T.... Fujimoto H.
|8|Urinary tumor marker in bladder carcinoma in Upper Egypt, correlations with different clinicopathological features. (22982928)
Salama R.H.... Bakar S.M.
|9|The varying faces of gall bladder carcinoma: pictorial essay. (22547386)
Lim K.S.... Tan C.H.
|10|Clinical usefulness of CEA, CA19-9, and CYFRA 21-1 as tumor markers for urothelial bladder carcinoma. (22041857)
Washino S.... Kobayashi Y.
|11|Second resection for non-muscle-invasive bladder carcinoma: current role and future perspectives. (20427121)
|12|External beam radiotherapy of bladder carcinoma: considerations in determining the irradiation field margins. (20941815)
Bozios G.... Tsekeris P.
|13|Editorial comment on: prognostic accuracy of individual uropathologists in noninvasive urinary bladder carcinoma: a multicentre study comparing the 1973 and 2004 World Health Organisation classifications. (19346064)
|14|New insights in intravesical treatment for intermediate- and high-risk non-muscle-invasive urothelial bladder carcinoma. (20080332)
|15|Inhibition of T24 human bladder carcinoma cell migration by RNA interference suppressing the expression of HD-PTP. (18835089)
Mariotti M.... Maier J.A.
|16|Bladder carcinoma presenting during twin pregnancy. (19065377)
Shrotri K.N.... Ross G.C.
|17|Antitumor activity of fibroblast growth factor receptor 3-specific immunotoxins in a xenograft mouse model of bladder carcinoma is mediated by apoptosis. (18413799)
MartA-nez-Torrecuadrada J.L.... Casal J.I.
|18|Sensitivity and specificity of p53 protein detection by immunohistochemistry in patients with urothelial bladder carcinoma. (18025850)
Salinas-SA!nchez A.S.... Escribano-MartA-nez J.
|19|Erysipeloid cutaneous metastasis from bladder carcinoma. (17951136)
Zangrilli A.... Chimenti S.
|20|Penoscrotal histoplasmosis following bladder carcinoma. (17593111)
Chaurasia D.... Bhargava A.
|21|The green tea compound, (-)-epigallocatechin-3-gallate downregulates N-cadherin and suppresses migration of bladder carcinoma cells. (17348027)
Rieger-Christ K.M.... Summerhayes I.C.
|22|Primary small cell bladder carcinoma: a case report and review of the current literature. (17260501)
Zachos I.... Deliveliotis C.
|23|Pseudoaneurysm embolization and vasopressin infusion for lower gastrointestinal bleeding due to recurrence of urinary bladder carcinoma. (16958402)
Kakizawa H.... Ito K.
|24|Proliferating cell nuclear antigen (PCNA) overexpression and microvessel density predict survival in the urinary bladder carcinoma. (16868689)
El-kott A.F.... Mokhtar A.A.
|25|Bladder carcinoma and HIV infection during the highly active antiretroviral therapy era: A rare, but intriguing association. Two case reports and literature review. (16798716)
Manfredi R.... Chiodo F.
|26|Qualitative and quantitative analysis of angiogenetic factors in transitional cell bladder carcinoma: relationship with clinical course at 10 years follow-up. (15944797)
Bartoletti R.... Rizzo M.
|27|Fas ligand and TNF-related apoptosis-inducing ligand induction on infiltrating lymphocytes in bladder carcinoma by bacillus Calmette-GuAcrin treatment. (16037714)
Mehmut M.... Fujime M.
|28|P16 immunoreactivity is an independent predictor of tumor progression in minimally invasive urothelial bladder carcinoma. (15774242)
KrA1ger S.... Feller A.C.
|29|Staging bladder carcinoma by three-dimensional ultrasound rendering. (15749550)
Wagner B.... Gottfried H.W.
|30|Papillary urothelial bladder carcinoma associated with osteoclast-like giant cells. (16132761)
KrA1ger S.... Feller A.C.
|31|Bladder carcinoma in situ in 2003: state of the art. (14733997)
|32|The expression and significance of survivin mRNA in urinary bladder carcinomas. (15138808)
Wang H.... Ge G.
|33|Detection of telomerase status by semiquantitative and in situ assays, and by real-time reverse transcription-polymerase chain reaction (telomerase reverse transcriptase) assay in bladder carcinomas. (12656916)
Longchampt E.... Lidereau R.
|34|Expression of lipoxygenase in human bladder carcinoma and growth inhibition by its inhibitors. (14532840)
Yoshimura R.... Nakatani T.
|35|The peroxisome proliferator-activated receptor gamma ligand 15-deoxy-Delta12,14-prostaglandin J2 induces vascular endothelial growth factor in the hormone-independent prostate cancer cell line PC 3 and the urinary bladder carcinoma cell line 5637. (12239635)
Haslmayer P.... Obrist P.
|36|PSCA expression is regulated by phorbol ester and cell adhesion in the bladder carcinoma cell line RT112. (11368875)
Bahrenberg G.... Jakse G.
|37|Frequent epigenetic inactivation of RASSF1A in human bladder carcinoma. (11559536)
Lee M.G.... Chi S.G.
|38|Expression of pS2 protein and its relation with the Ki-67 proliferative indices and tumor recurrence in superficial bladder carcinomas. (11528193)
Sagol O.... Kirkali Z.
|39|Chemosensitization of bladder carcinoma cells by bcl-xL antisense oligonucleotides. (11458048)
Lebedeva I.... Stein C.A.
|40|Noninvasive diagnosis of bladder carcinoma by enzyme-linked immunosorbent assay detection of CD44 isoforms in exfoliated urothelia. (10873090)
Woodman A.C.... Tarin D.
|41|Epidermal growth factor receptor (EGFR) in the prognosis of bladder carcinoma. Experience of 5 years]. (10900762)
Moreno Sierra J.... Resel EstAcvez L.
|42|Expression of cytokeratin 20 in urinary cytology of patients with bladder carcinoma. (9731913)
Southgate J.... Harnden P.
|43|Expression of three cell adhesion molecules in bladder carcinomas: correlation with pathological features. (9223755)
Mialhe A.... Seigneurin D.
|44|Expression of transforming growth factors beta-1, beta 2 and beta 3 in human bladder carcinomas. (9192977)
Eder I.E.... Klocker H.
|45|Expression of human chorionic gonadotropin beta subunit genes in superficial and invasive bladder carcinomas. (7543817)
Lazar V.... Vidaud M.
|46|Expression and secretion of the beta subunit of human chorionic gonadotropin by bladder carcinoma in vivo and in vitro. (7882356)
Nishimura R.... Baba S.
|47|HPV and p53 in urinary bladder carcinoma. (7808793)
Mincione G.P.... Calzolari A.
|48|neu is not involved in N-[4-(5-nitro-2-furyl)-2-thiazolyl]-formamide-induced bladder carcinoma or 2-amino-4-(5-nitro-2-furyl)thiazole transformation of rat bladder epithelial cells. (7915641)
Mann A.M.... Cohen S.M.
|49|Eosinophilic cystitis simulating invasive bladder carcinoma. (8351485)
Hansen M.V.... Kristensen P.B.
|50|Alterations in polymeric immunoglobulin receptor expression and secretory component levels in bladder carcinoma. (1759330)
Rossel M.... Vuitton D.A.